Hai-O Enterprise Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hai-O Enterprise Berhad with three other
drug stores in Asia:
Cosmo Bio Company Ltd
sales of 7.43 billion Japanese Yen [US$66.77 million]
of which 100%
was Reagent Research),
Sharehope Medicine Company Limited
(2.33 billion Taiwanese Dollars [US$76.69 million]
of which 53%
was Medicine Department), and
Excelsior Biopharma Inc
based in Taiwan
(1.54 billion Taiwanese Dollars [US$50.52 million]
Hai-O Enterprise Berhad reported sales of 297.63 million Malaysian Ringgits (US$69.41 million)
April of 2016.
increase of 24.1%
versus 2015, when the company's sales were 239.85 million Malaysian Ringgits.
Sales of Multi-Level Marketing saw an increase
46.3% in 2016, from
135.56 million Malaysian Ringgits to 198.28 million Malaysian Ringgits.
Not all segments of Hai-O Enterprise Berhad experienced an increase in sales in 2016:
sales of Retail fell 5.7% to 38.31 million Malaysian Ringgits.
Hai-O Enterprise Berhad also experienced decreases in sales in
Wholesale (down 3.9% to 54.36 million Malaysian Ringgits)
Others (down 5.5% to 6.69 million Malaysian Ringgits)